We talk to John Dennis, a data science researcher working in the University of Exeter. He used data from 1 million people with Type 2 diabetes to discover how the clinical characteristics of a patient alter the glucose lowering with different treatments. John’s 5 drug model, published in the Lancet in late February 2025, uses simple clinical information to identify, for the first time, the best glucose lowering treatment for a patient.  The model selected best treatment lowers the glucose most, doubles  the time before another medication is needed and reduces long term complications of diabetes. See www.1in6b.com for more details. Send us a text

Ver todos los episodios